Anbio Biotechnology Operating Cash Flow
Anbio Biotechnology (NNNN) reported Operating Cash Flow of -$6.74 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-04-07
| Period end | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|
| 2025-12-31 | -$6.74M 20-F · filed 2026-04-07 |
| 2024-12-31 | $2.08M 20-F · filed 2026-04-07 |
| 2023-12-31 | $898.37K 20-F · filed 2026-04-07 |
| 2022-12-31 | $4.45M 20-F · filed 2025-04-28 |